Publisher
Springer International Publishing
Reference40 articles.
1. Amadori S, Suciu S, Stasi R, Salih HR, Selleslag D, Muus P, De Fabritiis P, Venditti A, Ho AD, Lubbert M, Thomas X, Latagliata R, Halkes CJ, Falzetti F, Magro D, Guimaraes JE, Berneman Z, Specchia G, Karrasch M, Fazi P, Vignetti M, Willemze R, de Witte T, Marie JP (2013) Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17). J Clin Oncol 31(35):4424–4430. doi:10.1200/JCO.2013.49.0771
2. Andrews RG, Singer JW, Bernstein ID (1989) Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169(5):1721–1731
3. Aplenc R, Alonzo TA, Sung L, Meshinchi S, Gerbing RB, Raimondi SC, Hirsch B, Kahwash S, Heerema-McKenney A, Winter L, Glick K, Ccrp, Davies SM, Byron P, Smith FO (2013) Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk—Results From The Randomized Phase III Children's Oncology Group (COG) Trial, AAML0531. Blood 122(21):355–355
4. Audran R, Drenou B, Wittke F, Gaudin A, Lesimple T, Toujas L (1995) Internalization of human macrophage surface antigens induced by monoclonal antibodies. J Immunol Methods 188(1):147–154
5. Breccia M, Cimino G, Diverio D, Gentilini F, Mandelli F, Lo Coco F (2007) Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemia. Haematologica 92(9):1273–1274
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献